Insulin Injection Practices in Spain
Launched by FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL CLÍNICO DE VALENCIA · May 14, 2024
Trial Information
Current as of February 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
HYPOTHESIS The study hypothesis posits that there is significant variability in the practices of insulin administration among patients with diabetes using daily insulin injections. This diversity in administration practices may have a notable impact on the overall efficacy of treatment regimens and the successful management of the disease, thereby emphasizing the need for a comprehensive understanding of these practices to enhance patient outcomes and optimize diabetes care.
OBJECTIVES The main objective of the study is to comprehensively assess and characterize the diverse insulin adminis...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 or above
- • Individuals diagnosed with diabetes (type 1 or type 2 diabetes)
- • Individuals receiving multiple daily doses of insulin
- Exclusion Criteria:
- • Individuals utilizing continuous subcutaneous insulin infusion
- • Individuals engaging in sensor-augmented pump therapy
- • Individuals using automatic insulin delivery systems
Trial Officials
F. Javier Ampudia-Blasco
Principal Investigator
HCUV-INCLIVA
About Fundación Para La Investigación Del Hospital Clínico De Valencia
The Fundación para la Investigación del Hospital Clínico de Valencia is a prominent research organization dedicated to advancing medical knowledge and improving patient care through clinical trials and biomedical research. Based in Valencia, Spain, the foundation collaborates closely with the Hospital Clínico Universitario de Valencia to facilitate innovative studies across various medical disciplines. Its mission is to promote scientific excellence and foster collaboration among healthcare professionals, researchers, and institutions, ultimately aiming to translate research findings into effective therapies and interventions for the benefit of patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0